ICAN®—International Cancer Advocacy Network
Swing Fore Life Golf Invitational $25,000 Grant Presented to Broad Institute of MIT – Read more...
Oct. 21, 2019
Robert T. Hanlon, PhD, Exon 20 Group Co-Founder and Chair, presented a check for the $25,000 proceeds from the Swing Fore Life Golf Invitational to Heidi Greulich, PhD, Senior Group Leader in the Cancer Program at The Broad Institute of MIT and Harvard. Together with Dr. Matthew Meyerson, more...
Pictured from left: Robert T. Hanlon, Heidi Greulich and Bethany Kaplan.
ICAN® has a small staff and more than 1100 volunteers worldwide. With our volunteer leadership representing 17 different time zones, we literally work around the clock, focusing on our Personalized Medicine Cancer Case Navigation Programs, health information technology issues, legislative initiatives, and research projects.
We aim to provide you with the best patient advocates and the most effective cancer patient advocacy possible, with the twin goals of working to extend your life with the highest quality of life.
ICAN® advocates for you – the patient – or for the patient's spouse or family member who wants to manage the details of their loved one's cancer case with us.
We are beholden to no one – no oncology practice, no medical center, no clinical trial, and no biotech or pharmaceutical company.
Your case is unique and in our many years of non-stop advocacy services, we've never seen two patient cases remotely alike.
ICAN® empowers you to navigate rapidly-expanding diagnostic and personalized treatment options. This information will assist you in informed discussions with family and providers.
We never, ever, compromise patient privacy (zealous implementers of HIPAA) – We will not disclose your name or any identifying information, or exploit your case for fundraising purposes.
Federal Tax I.D.: EIN 86-0818253 | WA Charities: 37195
This website provides information about ICAN® Personalized Medicine Cancer Case Navigation Programs, while it also describes the ICAN® multi-faceted mission, unique vision, and respected values. Intended for use by the general public. This site also offers more in-depth information for target populations who may benefit from ICAN® Program Services such as ICAN® patients, their caregivers and medical teams — along with those healthcare professionals and researchers who are involved with ICAN® medical and scientific councils.
The health news displayed on this site are chosen by our team of M.D.s, PhDs, and ICAN® President and CEO, who is an Affiliate Member of ASCO, the American Society of Clinical Oncology; AMP, the Association for Molecular Pathology; and AACR, the American Association for Cancer Research. Information contained herein is therefore not intended to substitute for or supersede any advice that a patient receives from his/her health professional and is not intended to compromise in any way the patient-physician relationship. ICAN® strongly believes that all medical decisions need to be made, via shared decision-making, by the patient and his/her medical team.